Welcome
10 February 2012
Trial registration
Unique identification scheme
International databases
home
|
my details
|
ISRCTN Register
|
m
RCT
|
links
|
information
|
press
Find trials
ISRCTN Register
tips on searching
Registration
New application
Updating record
Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
International Standard Randomised Controlled Trial Number Register
Showing records:
5931
to
5940
of
10349
SEARCH FOR
RESULTS ORDER
DIRECTION
MAX RESULTS
Sponsor
ISRCTN
Date Assigned
Relevance
Ascending
Descending
10 per page
20 per page
50 per page
5931
Balloon angioplasty versus stenting with nitinol stents in the superficial femoral artery
ISRCTN:
ISRCTN52947529
Sponsor:
Medical University Vienna (Austria)
Date assigned:
26 May 2006
5932
Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phase
ISRCTN:
ISRCTN00721331
Sponsor:
Stanley Medical Research Institute (USA)
Date assigned:
25 May 2006
5933
Orlistat therapy in clozapine- and olanzapine-treated patients who are overweight or obese
ISRCTN:
ISRCTN65731856
Sponsor:
The Stanley Medical Research Institute (SMRI) (USA)
Date assigned:
25 May 2006
5934
Effect of a multidisciplinary in-patient rehabilitation program for patients with ankylosing spondylitis: a randomised controlled trial
ISRCTN:
ISRCTN75685576
Sponsor:
The Norwegian Government (Helse Øst)
Date assigned:
25 May 2006
5935
Randomised controlled trial of a specialist behaviour therapy team versus treatment as usual
ISRCTN:
ISRCTN62134865
Sponsor:
South Essex Partnership NHS Trust (UK)
Date assigned:
25 May 2006
5936
Bladder Cancer Prognosis Programme (incorporating SELENIB trial)
ISRCTN:
ISRCTN13889738
Sponsor:
University of Birmingham (United Kingdom)
Date assigned:
24 May 2006
5937
A phase I, single-dose, double-blind, randomised, dose escalation study to assess the safety, tolerability and pharmacokinetics of NNZ-2566 when administered as a 10-minute infusion
ISRCTN:
ISRCTN67656669
Sponsor:
Neuren Pharmaceuticals (New Zealand)
Date assigned:
24 May 2006
5938
Levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitaemia
ISRCTN:
ISRCTN27232551
Sponsor:
University of Oxford (United Kingdom)
Date assigned:
24 May 2006
5939
Ultrasound Cannulation of the Internal Jugular Vein
ISRCTN:
ISRCTN61258470
Sponsor:
General State Hospital of Athens (Greece)
Date assigned:
23 May 2006
5940
Randomised, controlled, multicenter, pilot study comparing qigong and back school for elderly patients with chronic neck pain
ISRCTN:
ISRCTN77101807
Sponsor:
Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
Date assigned:
23 May 2006
RESULT PAGE
|<
<
590
591
592
593
594
595
596
597
598
>
>|
© 2012 ISRCTN unless otherwise stated.